Skip to content

Randomised, crossover bioequivalence clinical trial of escitalopram 20 mg capsules versus escitalopram 20 mg film-coated tablets, after a single oral dose administration to healthy volunteers under fasting conditions

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2025-521069-28-00
Acronym
UECHUP-ESC/25-1
Enrollment
24
Registered
2025-03-04
Start date
2025-03-21
Completion date
2025-04-16
Last updated
2025-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antidepressants

Interventions

None listed

Sponsors

Alter Farmacia S.A.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026